Title : Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation.

Pub. Date : 2022 Mar

PMID : 35113170






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Since colchicine is an anti-inflammatory drug with the ability to block NLRP3 inflammasome oligomerization, this may prevent the release of active IL-1beta and block the detrimental effects of downstream cytokines, i.e. IL-6. Colchicine interleukin 1 alpha Homo sapiens